Letter From the Editor
Letter From the Editor: Addressing the Racial Gap in Health Care
Feature Article
Uterine Serous Carcinoma and Uterine Carcinosarcoma: Molecular Features, Clinical Advances, and Emerging Therapies
Abstract: Endometrial cancer, including high-grade subtypes, has a rising incidence and mortality. Uterine serous carcinoma (USC) and uterine carcinosarcoma (UCS) make up a small but increasing […]
In This Issue
From Recent Issues
Feature Article
Uterine Serous Carcinoma and Uterine Carcinosarcoma: Molecular Features, Clinical Advances, and Emerging Therapies
Abstract: Endometrial cancer, including high-grade subtypes, has a rising incidence and mortality. Uterine serous carcinoma (USC) and uterine carcinosarcoma (UCS) make up a small but increasing […]
Feature Article
Antibody-Drug Conjugates in Advanced Lung Cancer: Is This a New Frontier?
Abstract: Over the past decade, the lung cancer landscape has been dominated by targeted and immunotherapeutic approaches that have drastically shifted treatment paradigms for patients with […]
Feature Article
Redefining the Standard of Care for Low-Grade Serous Ovarian Cancer
Abstract: Low-grade serous carcinoma is a rare epithelial ovarian cancer subtype with distinct clinical, histologic, and molecular features. Improved understanding of this disease subtype has prompted […]
Supplements
NTRK Inhibitors
Efficacy and Safety of NTRK Inhibitors in Patients With NTRK Fusion–Positive Lung and Thyroid Cancers
Abstract: Neurotrophic tyrosine receptor kinase (NTRK) gene fusions are implicated in various cancers, including those of the lung and thyroid. The prevalence of NTRK fusions is 0.1 […]
Colorectal cancer
Improving Survival in Metastatic Colorectal Cancer Through Optimized Patient Selection
Abstract: The systemic treatment options for patients with metastatic colorectal cancer have recently expanded with the US Food and Drug Administration approval of fruquintinib being added to […]
Metastatic Breast Cancer
Highlights in Metastatic Breast Cancer From the 2023 San Antonio Breast Cancer Symposium
A Review of Selected Presentations From SABCS 2023 December 5-9, 2023 • San Antonio, Texas Clinical Outcomes by Age Subgroups in the Phase 3 TROPiCS-02 […]